Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call
MALVERN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing,...
Neuroscience
Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
Extends cash runway well into mid-2026; no new/replacement warrants issuedKENMORE, N.Y., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc....
SCbio 2025 Conference Showcases the Future of Life Sciences in South Carolina
SCbio unveils new campaign and industry pillars igniting growth in South Carolina's thriving life sciences ecosystem CHARLESTON, S.C., Feb. 20,...
SOBRsafe and Orbiit Announce Partnership to Enhance Alcohol Recovery Through AI and Wearable Technology
DENVER, Feb. 20, 2025 /PRNewswire/ -- SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe"), the leader in next-generation alcohol detection technology, and Orbiit, an...
OpenEvidence Achieves $1 Billion Valuation in Sequoia-led Round and Announces Content Partnership with the New England Journal of Medicine
CAMBRIDGE, Mass., Feb. 19, 2025 /PRNewswire/ -- OpenEvidence, the fastest-growing platform for doctors in history, has closed a Series A...
10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
PLEASANTON, Calif., Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology,...
Leadership in the Age of Artificial Intelligence: NSU to host AI Forum featuring Dr. Julian Bailes, Dr. Neilank Jha and Monty Chicola
NATCHITOCHES, La., Feb. 18, 2025 /PRNewswire/ -- Through the vision and leadership of President James Genovese, Northwestern State University is...
Soaak Technologies Launches ‘The Soaak Podcast’
Soaak Podcast Launches: Unlocking the Future of Bio-Optimization, Wellness Hacks, and Neuroscience for Peak Performance TULSA, Okla., Feb. 18, 2025...
FAU Joins the Nation’s Most Elite Research Universities and Colleges
Carnegie Classification of Institutions of Higher Education Designates FAU as 'R1: Very High Research Spending and Doctorate Production' BOCA RATON,...
Ketamine: From club drug to antidepressant?
Cold Spring Harbor Laboratory Professor Hiro Furukawa and postdoc Hyunook Kang prove the existence of a mysterious brain receptor known...
Remote Patient Monitoring Market to Hit USD 56.94 Billion by 2030 with 12.7% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Feb. 13, 2025 /PRNewswire/ -- The global remote patient monitoring market, valued at US$24.39 billion in 2023,...
Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform
MILAN, Feb. 13, 2025 /PRNewswire/ -- Newronika, a global leader in advanced deep brain stimulation, is pleased to announce the...
Augustine Therapeutics appoints Gerhard Koenig as Chief Executive Officer as Company Prepares to Enter the Clinic
Augustine Therapeutics appoints Gerhard Koenigas Chief Executive Officer as Company Prepares to Enter the Clinic Industry veteran Gerhard Koenig, PhD,...
Representative Sam Garrison Joined Tampa General Hospital and USF Health Morsani College Of Medicine to Highlight Innovation in Health Care at Florida’s State Capitol
TALLAHASSEE, Fla., Feb. 12, 2025 /PRNewswire/ -- Ahead of the 2025 legislative session, Representative Sam Garrison joined Tampa General Hospital...
Emmes Group advances data security as ISMS certified ISO compliant
Gold-standard accreditation underscores Emmes Group's commitment to secure and data-rich trials for biotech and pharma partners ROCKVILLE, Md., Feb. 12,...
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, including masked T-cell engagersXilio to...
Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
ROCKVILLE, Md., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025
DUBLIN, Feb. 11, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2024 full...
Stellaromics Secures Significant Funding to Advance 3D Spatial Biology
Investment Powers the Debut of Pyxa: A Groundbreaking Platform for 3D Spatial Biology Research BOSTON, Feb. 11, 2025 /PRNewswire/ -- Stellaromics,...
Firefly Neuroscience Accepted into NVIDIA Connect Program
Collaboration to provide Firefly with the technical resources to help further unleash the power of its FDA-cleared BNA™ platform For...